<!DOCTYPE html>
<!-- Generated by pkgdown: do not edit by hand --><html lang="en-US">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>What is NCA? • aNCA</title>
<script src="../lightswitch.js"></script><script src="../deps/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="../deps/bootstrap-5.3.1/bootstrap.min.css" rel="stylesheet">
<script src="../deps/bootstrap-5.3.1/bootstrap.bundle.min.js"></script><link href="../deps/font-awesome-6.5.2/css/all.min.css" rel="stylesheet">
<link href="../deps/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet">
<script src="../deps/headroom-0.11.0/headroom.min.js"></script><script src="../deps/headroom-0.11.0/jQuery.headroom.min.js"></script><script src="../deps/bootstrap-toc-1.0.1/bootstrap-toc.min.js"></script><script src="../deps/clipboard.js-2.0.11/clipboard.min.js"></script><script src="../deps/search-1.0.0/autocomplete.jquery.min.js"></script><script src="../deps/search-1.0.0/fuse.min.js"></script><script src="../deps/search-1.0.0/mark.min.js"></script><!-- pkgdown --><script src="../pkgdown.js"></script><link href="../extra.css" rel="stylesheet">
<meta property="og:title" content="What is NCA?">
<meta name="description" content="Background information on Non-Compartmental Analysis (NCA) and its applications in pharmacokinetics.
">
<meta property="og:description" content="Background information on Non-Compartmental Analysis (NCA) and its applications in pharmacokinetics.
">
</head>
<body>
    <a href="#main" class="visually-hidden-focusable">Skip to contents</a>


    <nav class="navbar navbar-expand-lg fixed-top " aria-label="Site navigation"><div class="container">

    <a class="navbar-brand me-2" href="../index.html">aNCA</a>

    <small class="nav-text text-muted me-auto" data-bs-toggle="tooltip" data-bs-placement="bottom" title="">0.1.0.9015</small>


    <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
      <span class="navbar-toggler-icon"></span>
    </button>

    <div id="navbar" class="collapse navbar-collapse ms-3">
      <ul class="navbar-nav me-auto">
<li class="nav-item"><a class="nav-link" href="../articles/aNCA.html">Get Started</a></li>
<li class="nav-item"><a class="nav-link" href="../reference/index.html">Functions manual</a></li>
<li class="active nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-contributing" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true">Contributing</button>
  <ul class="dropdown-menu" aria-labelledby="dropdown-contributing">
<li><a class="dropdown-item" href="../articles/contributing.html">Contributing</a></li>
    <li><a class="dropdown-item" href="../articles/adding_tlg.html">Adding TLGs</a></li>
    <li><a class="dropdown-item" href="../articles/design.html">Design &amp; Architecture</a></li>
    <li><a class="dropdown-item" href="../articles/background.html">NCA Concepts</a></li>
    <li><a class="dropdown-item" href="../articles/governance.html">Governance</a></li>
    <li><a class="dropdown-item" href="../articles/roadmap.html">Roadmap</a></li>
  </ul>
</li>
<li class="nav-item"><a class="nav-link" href="../articles/validations.html" aria-label="Validations"><span class="fa fa-check-circle"></span> Validation Plan</a></li>
<li class="nav-item"><a class="nav-link" href="../news/index.html">News &amp; Releases</a></li>
<li class="nav-item"><a class="nav-link" href="../articles/FAQs.html">FAQs</a></li>
      </ul>
<ul class="navbar-nav">
<li class="nav-item"><form class="form-inline" role="search">
 <input class="form-control" type="search" name="search-input" id="search-input" autocomplete="off" aria-label="Search site" placeholder="Search for" data-search-index="../search.json">
</form></li>
<li class="nav-item"><a class="external-link nav-link" href="https://github.com/pharmaverse/aNCA/" aria-label="GitHub"><span class="fa fab fa-github fa-lg"></span></a></li>
<li class="nav-item dropdown">
  <button class="nav-link dropdown-toggle" type="button" id="dropdown-lightswitch" data-bs-toggle="dropdown" aria-expanded="false" aria-haspopup="true" aria-label="Light switch"><span class="fa fa-sun"></span></button>
  <ul class="dropdown-menu dropdown-menu-end" aria-labelledby="dropdown-lightswitch">
<li><button class="dropdown-item" data-bs-theme-value="light"><span class="fa fa-sun"></span> Light</button></li>
    <li><button class="dropdown-item" data-bs-theme-value="dark"><span class="fa fa-moon"></span> Dark</button></li>
    <li><button class="dropdown-item" data-bs-theme-value="auto"><span class="fa fa-adjust"></span> Auto</button></li>
  </ul>
</li>
      </ul>
</div>


  </div>
</nav><div class="container template-article">




<div class="row">
  <main id="main" class="col-md-9"><div class="page-header">

      <h1>What is NCA?</h1>
            
      
      <small class="dont-index">Source: <a href="https://github.com/pharmaverse/aNCA/blob/main/vignettes/background.Rmd" class="external-link"><code>vignettes/background.Rmd</code></a></small>
      <div class="d-none name"><code>background.Rmd</code></div>
    </div>

    
    
<div class="section level2">
<h2 id="background-understanding-non-compartmental-analysis-nca-and-the-role-of-anca">Background: Understanding Non-Compartmental Analysis (NCA) and the
Role of aNCA<a class="anchor" aria-label="anchor" href="#background-understanding-non-compartmental-analysis-nca-and-the-role-of-anca"></a>
</h2>
<p>This document will help you understand the fundamentals of
Non-Compartmental Analysis (NCA) in pharmacokinetics (PK) and the
challenges analysts face when performing NCA. It also explains why the
aNCA application was developed and how it aims to streamline and enhance
the NCA workflow. For a video-content referring to all these concepts
you can also visit the <a href="#">R Pharma aNCA video (yet not
available)</a>.</p>
<div class="section level3">
<h3 id="what-is-pharmacokinetics-and-why-does-nca-matter">What is Pharmacokinetics and Why Does NCA Matter?<a class="anchor" aria-label="anchor" href="#what-is-pharmacokinetics-and-why-does-nca-matter"></a>
</h3>
<p>Drug development is not just about studying how drugs act on the body
(<em>pharmacodynamics</em>); it’s equally important to understand how
the body interacts with drugs. This is what we call
<strong>pharmacokinetics (PK)</strong>—the study of how drugs are
absorbed, distributed, metabolized, and excreted over time.</p>
<p>To visualize this, we use PK curves: graphs showing drug
concentration plotted against time after dosing. These curves tell us
how long a drug stays in the patient’s system, helping us determine the
optimal dose that balances efficacy and safety. The sweet spot—where
drug levels are high enough to have an effect but not so high as to
cause toxicity—is called the <strong>therapeutic window</strong>.</p>
<p><strong>One of the main goals of PK analysis is to calculate the dose
that achieves this window for the longest and safest
period.</strong></p>
<hr>
</div>
<div class="section level3">
<h3 id="what-is-non-compartmental-analysis-nca">What Is Non-Compartmental Analysis (NCA)?<a class="anchor" aria-label="anchor" href="#what-is-non-compartmental-analysis-nca"></a>
</h3>
<p>When it comes to evaluating PK data, analysis approaches can range
from simple to highly complex. On one end, you have
<strong>compartmental models</strong>, where drug movement between body
compartments (like blood, liver, or muscle) is described mathematically
using differential equations. On the other end, you have
<strong>Non-Compartmental Analysis (NCA)</strong>, which simplifies the
process by treating the body as a “black box.”</p>
<p>In NCA, instead of modeling how a drug moves between compartments, we
focus only on the <em>macroparameters</em>—high-level PK metrics that
describe overall drug behavior. These include: - <strong>AUC (Area Under
the Curve)</strong>: A measure of total drug exposure over time.<br>
- <strong>Cmax</strong>: The peak concentration of the drug in the
blood.<br>
- <strong>Tmax</strong>: The time it takes to reach peak
concentration.<br>
- <strong>Half-life
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>t</mi><mrow><mn>1</mn><mi>/</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">t_{1/2}</annotation></semantics></math>)</strong>:
The time required for the drug concentration to drop by half, which
helps calculate elimination rates.</p>
<p>Because NCA calculations are <strong>model-independent</strong>, they
make fewer assumptions about drug distribution and can often provide
quick, robust results.</p>
<hr>
</div>
<div class="section level3">
<h3 id="key-calculations-in-nca">Key Calculations in NCA<a class="anchor" aria-label="anchor" href="#key-calculations-in-nca"></a>
</h3>
<div class="section level4">
<h4 id="area-under-the-curve-auc">
<strong>1. Area Under the Curve (AUC):</strong><a class="anchor" aria-label="anchor" href="#area-under-the-curve-auc"></a>
</h4>
<ul>
<li>AUC represents the total drug exposure in the body.</li>
<li>It’s calculated by summing up the areas under the concentration-time
curve using methods like the trapezoidal rule.</li>
<li>Two common AUC calculations are:
<ul>
<li>
<strong>AUClast</strong>: Exposure up to the last measurable
concentration (the one before concentrations falling below quantifiable
levels, BLQ).</li>
<li>
<strong>AUCinf</strong>: Total exposure to infinity, including
extrapolated data beyond the last measurable point (requires estimating
a slope from the terminal phase).</li>
</ul>
</li>
</ul>
</div>
<div class="section level4">
<h4 id="half-life-t_12">
<strong>2. Half-Life
(<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>t</mi><mrow><mn>1</mn><mi>/</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">t_{1/2}</annotation></semantics></math>):</strong><a class="anchor" aria-label="anchor" href="#half-life-t_12"></a>
</h4>
<ul>
<li>Derived from the terminal slope of the concentration-time
curve.</li>
<li>Half-life impacts key PK calculations, including AUCinf and
clearance, making it critical to get this value right.</li>
<li>Analysts may allow <strong>customization</strong> of
<math display="inline" xmlns="http://www.w3.org/1998/Math/MathML"><semantics><msub><mi>t</mi><mrow><mn>1</mn><mi>/</mi><mn>2</mn></mrow></msub><annotation encoding="application/x-tex">t_{1/2}</annotation></semantics></math>
using methods like manual slope selection to exclude outliers or focus
on more reliable data points.</li>
</ul>
</div>
<div class="section level4">
<h4 id="other-calculations">
<strong>3. Other Calculations:</strong><a class="anchor" aria-label="anchor" href="#other-calculations"></a>
</h4>
<ul>
<li>
<strong>Partial AUCs:</strong> Focused on specific time intervals
(e.g., 0-8 hours) to evaluate absorption or distribution phases.</li>
<li>
<strong>Parameter Ratios:</strong> Comparison of exposure levels
(e.g., metabolite-to-parent ratios) for deeper insights into the drug’s
behavior.</li>
<li>
<strong>Clearance and Volume of Distribution:</strong> Derived from
AUC and half-life, these parameters help understand how efficiently the
body eliminates the drug and how widely it distributes.</li>
</ul>
<hr>
</div>
</div>
<div class="section level3">
<h3 id="challenges-and-common-actions-in-nca-analysis">Challenges and Common Actions in NCA Analysis<a class="anchor" aria-label="anchor" href="#challenges-and-common-actions-in-nca-analysis"></a>
</h3>
<p>Despite its mathematical simplicity, <strong>performing NCA can be
operationally complex</strong>, especially in a corporate or regulatory
setting. Here is why:</p>
<div class="section level4">
<h4 id="pre-analysis-steps">
<strong>1. Pre-Analysis Steps</strong>:<a class="anchor" aria-label="anchor" href="#pre-analysis-steps"></a>
</h4>
<ul>
<li>
<strong>Exclusions:</strong> Identifying which data points
(outliers, missing data, or post-dose anomalies) should be excluded from
the analysis.</li>
<li>
<strong>Method Selection:</strong> Analysts decide which slope
estimation, extrapolation techniques, or AUC intervals are most
appropriate.</li>
<li>
<strong>Customized Intervals:</strong> Tailoring intervals for
partial AUCs or adding coefficient ratios.</li>
</ul>
</div>
<div class="section level4">
<h4 id="data-preparation">
<strong>2. Data Preparation</strong>:<a class="anchor" aria-label="anchor" href="#data-preparation"></a>
</h4>
<ul>
<li>PK analysis requires significant <strong>data cleaning, preparation,
and mapping</strong>. The data follows strict standards, such as
<strong>CDISC SDTM</strong>, to ensure it can be used directly in
regulatory workflows.</li>
<li>Here’s where roles emerge: A <strong>data collector</strong> works
on SDTM datasets, a <strong>statistical programmer</strong> processes
the data to make it analysis-ready, and a <strong>PK analyst</strong>
performs the NCA calculations.</li>
</ul>
</div>
<div class="section level4">
<h4 id="post-analysis-steps-cdisc-outputs-and-reporting">
<strong>3. Post-Analysis Steps (CDISC Outputs and
Reporting)</strong>:<a class="anchor" aria-label="anchor" href="#post-analysis-steps-cdisc-outputs-and-reporting"></a>
</h4>
<ul>
<li>Output from NCA must meet <strong>CDISC compliance</strong>
standards for submission to regulatory agencies like the FDA or EMA.
Typical datasets include:
<ul>
<li>
<strong>PP (Pharmacokinetic Parameters):</strong> Lists
macroparameters (e.g., AUC, Tmax, Cmax, half-life) for each
individual.</li>
<li>
<strong>ADPP (Analysis Dataset for Pharmacokinetic
Parameters):</strong> A more detailed, CDISC-compliant dataset linked to
analysis-ready inputs.</li>
</ul>
</li>
<li>Outputs are used to generate <strong>Tables, Listings, and Graphs
(TLGs)</strong>, which are essential in <strong>dose-escalation
studies</strong>, bioequivalence trials, and drug approval submissions.
These provide visual, tabular, and narrative summaries of the NCA
results, allowing stakeholders and regulators to understand findings at
a glance.</li>
</ul>
<hr>
</div>
</div>
<div class="section level3">
<h3 id="why-do-we-need-anca">Why Do We Need aNCA?<a class="anchor" aria-label="anchor" href="#why-do-we-need-anca"></a>
</h3>
<p>Despite its simplicity, NCA workflows often become a bottleneck in
drug development due to inefficiencies and heavy manual interventions: -
Fragmented workflows require coordination between multiple roles (data
collectors, programmers, analysts). - Many NCA tools are proprietary,
expensive, and lack flexibility for custom needs. - Errors introduced
during manual data handling lead to reproducibility challenges and
delays.</p>
<p>This is why we created <strong>aNCA</strong>: - To simplify and unify
the entire NCA process, from data preparation to generating
CDISC-compliant outputs. - To empower analysts, even those without
extensive programming experience, by offering a <strong>user-friendly
interface</strong> built on <strong>PKNCA</strong>, an open-source R
package for NCA in pharmacokinetics. - To increase automation and reduce
errors, ensuring a faster and reproducible workflow.</p>
</div>
<div class="section level3">
<h3 id="do-you-want-to-know-more">Do you want to know more?<a class="anchor" aria-label="anchor" href="#do-you-want-to-know-more"></a>
</h3>
<p>Here is a list of recommended links to deepen your understanding of
NCA and related concepts: - <a href="#">R Pharma aNCA video - yet not
available</a> - Here you can find a video explaining NCA main concepts
and how aNCA works.</p>
</div>
</div>
  </main><aside class="col-md-3"><nav id="toc" aria-label="Table of contents"><h2>On this page</h2>
    </nav></aside>
</div>



    <footer><div class="pkgdown-footer-left">
  <p>Developed by Ercan Suekuer, Gerardo Jose Rodriguez, Pascal Baertschi, Jana Spinner, Mateusz Kolomanski, Lucy Aspridis, Valentin Legras, F. Hoffmann-La Roche AG.</p>
</div>

<div class="pkgdown-footer-right">
  <p>Site built with <a href="https://pkgdown.r-lib.org/" class="external-link">pkgdown</a> 2.2.0.</p>
</div>

    </footer>
</div>





  </body>
</html>
